EXO EYE Revitalizing Eye Balm

Route: Topical periorbital application only.

Using a fingertip or the clean ring finger (which naturally applies the lightest pressure), gently tap a small amount of balm along the orbital bone and under-eye area. Avoid direct application to the eyelid margin or inside the lower lid margin to prevent ocular contact. Apply morning, evening, or as directed by the prescribing clinician. The balm base provides an occlusive barrier that supports nighttime skin recovery when used as a bedtime preparation. Do not use in the eye.

Application frequency is prescriber-directed. Typical practice for periorbital preparations:

• Apply a small pea-sized amount to the periorbital area once or twice daily.
• Consistency over 8–12 weeks is recommended before a formal clinical assessment.
• If used in conjunction with any laser or energy-based periorbital procedures, application timing should be determined by the treating clinician.

The periorbital skin is the thinnest skin on the body (as little as 0.5 mm dermis), making it particularly vulnerable to collagen loss, oxidative damage, and visible aging changes. Extracellular vesicles in EXO EYE target periorbital aging mechanisms:

• Growth factors (TGF-β, VEGF, FGF) delivered by the vesicles stimulate periorbital fibroblasts to synthesize collagen and elastin, improving skin thickness and elasticity.
• Anti-inflammatory miRNA cargo reduces vascular permeability and local inflammatory signaling that contribute to periorbital puffiness and dark circles (dark circles with an inflammatory component).
• The occlusive balm vehicle prevents trans-epidermal water loss (TEWL) in this barrier-compromised region, supporting the hydration that makes fine lines less visible.
• Antioxidant proteins within vesicle cargo attenuate UV and environmental oxidative damage to periorbital fibroblasts.

Clinical Context: EXO EYE is designed for prescriber-directed use in patients presenting with periorbital aging — including fine lines (crow's feet, under-eye lines), loss of periorbital skin thickness, puffiness, and dark circles with an inflammatory or hyperpigmentary component. The periorbital region requires specialized, low-irritant preparations due to its exceptional skin thinness and proximity to the ocular surface. The balm format provides both ingredient delivery and occlusive barrier support.

Monitoring Considerations:

• Evaluate periorbital skin quality and patient-reported outcomes at 8–12 weeks.
• Ensure patients are applying correctly — with light pressure and away from the direct ocular surface — to avoid ocular adverse events.
• Monitor for any signs of allergic contact dermatitis in this sensitive anatomic region.

Contraindications:

• Known hypersensitivity to any component of the balm or its excipients.
• Active ocular infection or periorbital dermatitis.

Warnings & Precautions:

• For periorbital external use only. Do not apply inside the eyelid or directly onto the ocular surface. If accidental ocular contact occurs, rinse thoroughly with clean water.
• The periorbital skin is particularly sensitive; discontinue use if persistent irritation, urticaria, or contact dermatitis develops.
• Balm preparations may blur vision temporarily if they migrate into the eye; apply minimal amounts at the orbital rim.

Drug Interactions:

• No established pharmacokinetic interactions. Avoid combining with high-concentration periorbital retinoids or exfoliants in the same application session without prescriber guidance, as simultaneous use may increase irritation in this sensitive region.

Common Side Effects: Generally well tolerated. Mild periorbital irritation, heaviness of the balm vehicle, or mild transient erythema may occur. Ocular irritation if the preparation migrates to the ocular surface.

Store at controlled room temperature (20–25°C / 68–77°F) or as directed on the label. Protect from heat and light. If the formulation contains heat-sensitive vesicle components, refrigeration at 2–8°C may be required — see the prescription label. Keep out of reach of children. Use before the BUD assigned by Genesis Compounding.

Is it safe to use this so close to my eyes?

Yes, when applied correctly — to the orbital bone and surrounding skin rather than directly on the eyelid or inside the lash line. Use the ring finger with light tapping motions. Do not apply to the eyelid margin, and avoid direct ocular contact. If the preparation reaches the eye, rinse with clean water.

Will this help with dark circles?

Dark circles have multiple causes (vascular, pigmentary, anatomical shadowing). EXO EYE addresses the inflammatory and vascular components through anti-inflammatory exosome signaling. Pigmentary and anatomical shadow causes may require additional treatments. Your prescriber can recommend a comprehensive periorbital plan.

Can I use this after laser or other periorbital procedures?

Exosome preparations are frequently used in post-procedure recovery protocols to support skin healing. The appropriate timing relative to any procedure should be coordinated with your treating clinician.

Is this FDA-approved?

No. This is a prescription-only 503A compounded preparation made by Genesis Compounding per your prescriber's specifications.

How often should I apply it?

Your prescriber will specify the frequency. Most periorbital preparations are applied once or twice daily. Evening application allows the occlusive balm base to work during sleep without exposure to environmental factors.